Related Experiment Video
Updated: May 25, 2026

07:13
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three
I Ray-Coquard1, M C Montesco2, J M Coindre3
1University Lyon, EAM 4129 Health Individual Society, Hôtel Dieu, Lyon; Centre Léon Bérard, Lyon, France.
Summary
A second opinion (SO) significantly impacts sarcoma diagnosis. Over 40% of initial histological diagnoses were altered after expert review, potentially changing patient treatment plans.
Area of Science:
- Oncology
- Pathology
- Cancer Research
Background:
- Sarcomas are a diverse group of cancers requiring precise diagnosis.
- Accurate histological diagnosis and prognostic factors are crucial for effective sarcoma treatment.
- The impact of second opinions on sarcoma diagnostic accuracy lacks population-based evidence.
Purpose of the Study:
- To evaluate the contribution of second opinions to diagnostic accuracy in population-based sarcoma studies.
- To assess the rate of concordance and discordance between initial histological diagnoses and expert second opinions.
Main Methods:
- Histological data from sarcoma patients in three French and Italian regions were collected over two years.
- Initial diagnoses were systematically compared against second opinions provided by regional and national experts.
Main Results:
- Out of 2016 patients, 1463 met inclusion criteria for analysis.
- Full diagnostic concordance was achieved in 56% of cases.
- Partial concordance (same tumor type, different grade/subtype) occurred in 35%, and complete discordance in 8% of cases.
- Major discrepancies involved histological grade (43%), type (24%), and subtype (3%).
Conclusions:
- Over 40% of initial sarcoma histological diagnoses were modified upon expert second review.
- These diagnostic revisions may lead to altered treatment strategies for sarcoma patients.